XML 134 R124.htm IDEA: XBRL DOCUMENT v3.24.1
Parent Company Only Condensed Financial Information - Schedule of Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
OPERATING ACTIVITIES      
Net (loss) income $ (11,712) $ (11,968) $ 5,598
Adjustments:      
Amortization of premiums and discounts   (204) (1,947)
Net cash (used in) provided by operating activities   (10) 2,344
INVESTING ACTIVITIES      
Net cash acquired through merger and acquisition   41,745  
Sale of securities   91,364 513
Net cash provided by (used in) investing activities   58,583 (222,590)
FINANCING ACTIVITIES      
Proceeds from issuance of common stock, net   10,132 34,650
Proceeds from issuance of subordinated notes     20,000
Issuance of shares from exercise of stock options   150 120
Dividends paid   (4,870) (3,334)
Net cash (used in) provided by financing activities   (8,394) 227,667
(Decrease) Increase in cash and cash equivalents   50,179 7,421
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD   30,011 22,590
CASH AND CASH EQUIVALENTS AT END OF PERIOD 80,190 80,190 30,011
Parent Company [Member]      
OPERATING ACTIVITIES      
Net (loss) income   (11,968) 5,598
Adjustments:      
Undistributed earnings of subsidiaries   6,035 (7,245)
Amortization of premiums and discounts   (118) (212)
Other, net   (549) (1,171)
Net cash (used in) provided by operating activities   (6,600) (3,030)
INVESTING ACTIVITIES      
Net cash acquired through merger and acquisition   8,014 0
Investments in subsidiaries   (10,400) (35,000)
Cash dividends from subsidiaries   0 1,300
Sale of securities     504
Net cash from dissolution of subsidiary   635 0
Net cash provided by (used in) investing activities   (1,751) (33,196)
FINANCING ACTIVITIES      
Proceeds from issuance of common stock, net   10,132 34,650
Proceeds from issuance of subordinated notes   0 20,000
Issuance of shares from exercise of stock options   150 120
Dividends paid   (4,870) (3,334)
Net cash (used in) provided by financing activities   5,412 51,436
(Decrease) Increase in cash and cash equivalents   (2,939) 15,210
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD   15,486 276
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 12,547 $ 12,547 $ 15,486